Pierre Fenaux
AuthID: R-00F-KZD
1
TITLE: Sickle cell disease landscape and challenges in the EU the ERN-EuroBloodNet perspective
AUTHORS: Pereira, Maria del Mar Manu; Colombatti, Raffaella; Alvarez, Federico; Bartolucci, Pablo; Bento, Celeste; Brunetta, Angelo Loris; Cela, Elena; Christou, Soteroula; Collado, Anna; de Montalembert, Mariane; Dedeken, Laurence; Fenaux, Pierre; Galacteros, Frederic; Glenthoj, Andreas; Valle, Victoria Gutierrez; Kattamis, Antonis; Kunz, Joachim; Lobitz, Stephan; McMahon, Corrina; Pellegrini, Mariangela; ...More
PUBLISHED: 2023, SOURCE: LANCET HAEMATOLOGY, VOLUME: 10, ISSUE: 8
AUTHORS: Pereira, Maria del Mar Manu; Colombatti, Raffaella; Alvarez, Federico; Bartolucci, Pablo; Bento, Celeste; Brunetta, Angelo Loris; Cela, Elena; Christou, Soteroula; Collado, Anna; de Montalembert, Mariane; Dedeken, Laurence; Fenaux, Pierre; Galacteros, Frederic; Glenthoj, Andreas; Valle, Victoria Gutierrez; Kattamis, Antonis; Kunz, Joachim; Lobitz, Stephan; McMahon, Corrina; Pellegrini, Mariangela; ...More
PUBLISHED: 2023, SOURCE: LANCET HAEMATOLOGY, VOLUME: 10, ISSUE: 8
INDEXED IN: 
Scopus 
WOS
Scopus WOS2
TITLE: Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study
AUTHORS: Heiblig, Mael; Ferrada, Marcela A.; Koster, Matthew T.; Barba, Thomas; Gerfaud Valentin, Mathieu; Mekinian, Arsene; Coelho, Henrique; Fossard, Gaelle; Barraco, Fiorenza; Galicier, Lionel; Bienvenu, Boris; Hirsch, Pierre; Vial, Guillaume; Boutin, Anne Blandine; Galland, Joris; Le Guenno, Guillaume; Bigot, Adrien; Warrington, Kenneth J.; Kermani, Tanaz A.; Grayson, Peter C.; ...More
PUBLISHED: 2022, SOURCE: BLOOD, VOLUME: 140, ISSUE: 8
AUTHORS: Heiblig, Mael; Ferrada, Marcela A.; Koster, Matthew T.; Barba, Thomas; Gerfaud Valentin, Mathieu; Mekinian, Arsene; Coelho, Henrique; Fossard, Gaelle; Barraco, Fiorenza; Galicier, Lionel; Bienvenu, Boris; Hirsch, Pierre; Vial, Guillaume; Boutin, Anne Blandine; Galland, Joris; Le Guenno, Guillaume; Bigot, Adrien; Warrington, Kenneth J.; Kermani, Tanaz A.; Grayson, Peter C.; ...More
PUBLISHED: 2022, SOURCE: BLOOD, VOLUME: 140, ISSUE: 8
INDEXED IN: WOS
WOS3
TITLE: Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes
AUTHORS: Garcia Manero, G; Santini, V; Almeida, A; Platzbecker, U; Jonasova, A; Silverman, LR; Falantes, J; Reda, G; Buccisano, F; Fenaux, P; Buckstein, R; Campelo, MD; Larsen, S; Valcarcel, D; Vyas, P; Giai, V; Oliva, EN; Shortt, J; Niederwieser, D; Mittelman, M; ...More
PUBLISHED: 2021, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 39, ISSUE: 13
AUTHORS: Garcia Manero, G; Santini, V; Almeida, A; Platzbecker, U; Jonasova, A; Silverman, LR; Falantes, J; Reda, G; Buccisano, F; Fenaux, P; Buckstein, R; Campelo, MD; Larsen, S; Valcarcel, D; Vyas, P; Giai, V; Oliva, EN; Shortt, J; Niederwieser, D; Mittelman, M; ...More
PUBLISHED: 2021, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 39, ISSUE: 13
INDEXED IN: Scopus WOS
Scopus WOS4
TITLE: Clinical Efficacy of JAK Inhibitors in Patients with Vexas Syndrome: A Multicenter Retrospective Study
AUTHORS: Heiblig, Mael; Ferrada, Marcela A.; Gerfaud Valentin, Mathieu; Barba, Thomas; Mekinian, Arsene; Koster, Matthew; Coelho, Henrique; Fossard, Gaelle; Barraco, Fiorenza; Galicier, Lionel; Bienvenu, Boris; Hirsch, Pierre; Vial, Guillaume; Boutin, Anne Blandine; Le Guenno, Guillaume; Bigot, Adrien; Warrington, Kenneth; Kermani, Tanaz; Jamilloux, Yvan; Grayson, Peter C.; ...More
PUBLISHED: 2021, SOURCE: BLOOD, VOLUME: 138
AUTHORS: Heiblig, Mael; Ferrada, Marcela A.; Gerfaud Valentin, Mathieu; Barba, Thomas; Mekinian, Arsene; Koster, Matthew; Coelho, Henrique; Fossard, Gaelle; Barraco, Fiorenza; Galicier, Lionel; Bienvenu, Boris; Hirsch, Pierre; Vial, Guillaume; Boutin, Anne Blandine; Le Guenno, Guillaume; Bigot, Adrien; Warrington, Kenneth; Kermani, Tanaz; Jamilloux, Yvan; Grayson, Peter C.; ...More
PUBLISHED: 2021, SOURCE: BLOOD, VOLUME: 138
INDEXED IN: WOS
WOS5
TITLE: Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes Full Text
AUTHORS: Louise de Swart; Simon Crouch; Marlijn Hoeks; Alex Smith; Saskia Langemeijer; Pierre Fenaux; Argiris Symeonidis; Jaroslav Cermak; Eva Hellstrom Lindberg; Reinhard Stauder; Guillermo Sanz; Moshe Mittelman; Mette Skov Holm; Luca Malcovati; Krzysztof Madry; Ulrich Germing; Aurelia Tatic; Aleksandar Savic; Antonio Medina Almeida; Njetocka Gredelj Simec; ...More
PUBLISHED: 2020, SOURCE: HAEMATOLOGICA, VOLUME: 105, ISSUE: 3
AUTHORS: Louise de Swart; Simon Crouch; Marlijn Hoeks; Alex Smith; Saskia Langemeijer; Pierre Fenaux; Argiris Symeonidis; Jaroslav Cermak; Eva Hellstrom Lindberg; Reinhard Stauder; Guillermo Sanz; Moshe Mittelman; Mette Skov Holm; Luca Malcovati; Krzysztof Madry; Ulrich Germing; Aurelia Tatic; Aleksandar Savic; Antonio Medina Almeida; Njetocka Gredelj Simec; ...More
PUBLISHED: 2020, SOURCE: HAEMATOLOGICA, VOLUME: 105, ISSUE: 3
INDEXED IN: Scopus WOS
Scopus WOS6
TITLE: Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS Full Text
AUTHORS: Louise de Swart; Alex Smith; Detlef Haase; Pierre Fenaux; Argiris Symeonidis; Jaroslav Cermak; Guillermo Sanz; Reinhard Stauder; Moshe Mittelman; Eva Hellstrom Lindberg; Luca Malcovati; Saskia Langemeijer; Mette Skov Holm; Krzysztof Madry; Ulrich Germing; Antonio Medina Almeida; Aurelia Tatic; Aleksandar Savic; Njetocka Gredelj Simec; Corine van Marrewijk; ...More
PUBLISHED: 2018, SOURCE: LEUKEMIA RESEARCH, VOLUME: 67
AUTHORS: Louise de Swart; Alex Smith; Detlef Haase; Pierre Fenaux; Argiris Symeonidis; Jaroslav Cermak; Guillermo Sanz; Reinhard Stauder; Moshe Mittelman; Eva Hellstrom Lindberg; Luca Malcovati; Saskia Langemeijer; Mette Skov Holm; Krzysztof Madry; Ulrich Germing; Antonio Medina Almeida; Aurelia Tatic; Aleksandar Savic; Njetocka Gredelj Simec; Corine van Marrewijk; ...More
PUBLISHED: 2018, SOURCE: LEUKEMIA RESEARCH, VOLUME: 67
INDEXED IN: Scopus WOS
Scopus WOS7
TITLE: Safety profile of lenalidomide in patients with lower-risk myelodysplastic syndromes without del(5q): results of a phase 3 trial
AUTHORS: Antonio Almeida; Pierre Fenaux; Guillermo Garcia Manero; Stuart L Goldberg; Stefanie Groepper; Anna Jonasova; Norbert Vey; Carmen Castaneda; Jianhua H Zhong; Beach, CL; Valeria Santini;
PUBLISHED: 2018, SOURCE: LEUKEMIA & LYMPHOMA, VOLUME: 59, ISSUE: 9
AUTHORS: Antonio Almeida; Pierre Fenaux; Guillermo Garcia Manero; Stuart L Goldberg; Stefanie Groepper; Anna Jonasova; Norbert Vey; Carmen Castaneda; Jianhua H Zhong; Beach, CL; Valeria Santini;
PUBLISHED: 2018, SOURCE: LEUKEMIA & LYMPHOMA, VOLUME: 59, ISSUE: 9
INDEXED IN: WOS
WOS8
TITLE: IMPACT OF GENE MUTATIONS ON RESPONSE TO LENALIDOMIDE AND OS IN LOWER-RISK NON-DEL(5Q) MDS PATIENTS INELIGIBLE/REFRACTORY TO ERYTHROPOIESIS-STIMULATING AGENTS (ESAS) Full Text
AUTHORS: Santini, V; Fenaux, P; Giagounidis, A; Platzbecker, U; Almeida, A; List, AF; Zhong, J; Wu, C; Mavrommatis, K; Beach, CL; MacBeth, KJ;
PUBLISHED: 2017, SOURCE: 14th International Symposium on Myelodysplastic Syndromes (MDS) in LEUKEMIA RESEARCH, VOLUME: 55
AUTHORS: Santini, V; Fenaux, P; Giagounidis, A; Platzbecker, U; Almeida, A; List, AF; Zhong, J; Wu, C; Mavrommatis, K; Beach, CL; MacBeth, KJ;
PUBLISHED: 2017, SOURCE: 14th International Symposium on Myelodysplastic Syndromes (MDS) in LEUKEMIA RESEARCH, VOLUME: 55
INDEXED IN: WOS
WOS9
TITLE: IMPACT OF GENE MUTATIONS ON RESPONSE TO LENALIDOMIDE AND OS IN LOWER-RISK NON-DEL(5Q) MDS PATIENTS INELIGIBLE/REFRACTORY TO ERYTHROPOIESIS-STIMULATING AGENTS (ESAS) Full Text
AUTHORS: Santini, V; Fenaux, P; Giagounidis, A; Platzbecker, U; Almeida, A; List, AF; Zhong, J; Wu, C; Mavrommatis, K; Beach, CL; MacBeth, KJ;
PUBLISHED: 2017, SOURCE: 46th Congress of the Italian-Society-of-Hematology in HAEMATOLOGICA, VOLUME: 102
AUTHORS: Santini, V; Fenaux, P; Giagounidis, A; Platzbecker, U; Almeida, A; List, AF; Zhong, J; Wu, C; Mavrommatis, K; Beach, CL; MacBeth, KJ;
PUBLISHED: 2017, SOURCE: 46th Congress of the Italian-Society-of-Hematology in HAEMATOLOGICA, VOLUME: 102
INDEXED IN: WOS
WOS10
TITLE: Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents
AUTHORS: Valeria Santini; Antonio Almeida; Aristoteles Giagounidis; Stefanie Groepper; Anna Jonasova; Norbert Vey; Ghulam J Mufti; Rena Buckstein; Moshe Mittelman; Uwe Platzbecker; Ofer Shpilberg; Ron Ram; Consuelo del Canizo; Norbert Gattermann; Keiya Ozawa; Alberto Risueno; Kyle J MacBeth; Jianhua H Zhong; Francis Seguy; Albert Hoenekopp; ...More
PUBLISHED: 2016, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 34, ISSUE: 25
AUTHORS: Valeria Santini; Antonio Almeida; Aristoteles Giagounidis; Stefanie Groepper; Anna Jonasova; Norbert Vey; Ghulam J Mufti; Rena Buckstein; Moshe Mittelman; Uwe Platzbecker; Ofer Shpilberg; Ron Ram; Consuelo del Canizo; Norbert Gattermann; Keiya Ozawa; Alberto Risueno; Kyle J MacBeth; Jianhua H Zhong; Francis Seguy; Albert Hoenekopp; ...More
PUBLISHED: 2016, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 34, ISSUE: 25
